GlobeNewswire

Surplus for Swedish central government in October 2019

Share

Swedish central government payments resulted in a surplus of SEK 31.9 billion in October. The Debt Office's forecast was a surplus of SEK 30.2 billion. The difference was mainly due to the Debt Office’s net lending being lower than expected.

The primary balance was SEK 0.7 billion lower than predicted. Tax income was approximately SEK 4 billion lower than forecasted, due to higher outflows from tax accounts than expected. This was offset by lower payments from several authorities, including the Swedish Migration Agency and the Swedish Transport Administration.

The Debt Office’s net lending to government agencies etc. was SEK 2.2 billion lower than anticipated. This is mainly due to lower lending to mainly the Swedish Transport Administration and Svenska kraftnät. In addition, the deposits were higher than expected. The Riksbank has repaid, as expected, a loan in foreign currency which lowered the net lending. The repayment of the loan by the Riksbank strengthens the budget surplus with approximately SEK 26 billion.

Interest payments on central government debt were SEK 0.2 billion lower than calculated.

For the twelve-month period up to the end of October 2019, central government payments resulted in a surplus of SEK 122.4 billion. An amount corresponding to SEK 69 billion is included in the surplus. This amount is due to the repayment of loans in foreign currency by the Riksbank to the Debt Office.

Central government debt amounted to SEK 1 035 billion at the end of October.

The outcome for November 2019 will be published on 6 December at 9.30 a.m.

Contact

Elin Stenbacka, Macroeconomist, +46 (0)8 613 45 99
Press Secretary, +46 (0)8 613 47 01

Budget balance and central government net borrowing requirement1 (SEK million)  
  Outcome Oct. Forecast Oct. Deviation Oct. Acc.  Dev2 Outcome 12-month
Budget balance 31 874 30 235 1 639 1 639 122 401
Net borrowing requirement -31 874 -30 235 -1 639 -1 639 -122 401
Primary balance3 641 -107 748 748 -74 219
Net lending to agencies etc.4 -31 307 -29 113 -2 193 -2 193 -69 588
Interest payments on central government debt -1 208 -1 015 -193 -193 21 406
  - Interest on loans in SEK -1 888 -1 425 -463 -463 17 405
  - Interest on loans in foreign currency 14 -124 138 138 -330
  - Realised currency gains and losses 666 534 132 132 4 331
1 The net borrowing requirement corresponds to the budget balance with opposite sign.
2 Sum of monthly forecast deviations since last forecast (October 2019).
3 Net of the state's primary expenditure and income.
4 The net of government agencies etc. deposits and loans in the state’s internal bank. The net lending includes
  both current government operations and temporary occurrences which can be decided on short notice. The net
  lending affects the net borrowing requirement and central government debt, but are not covered by the
  Central government expenditure ceiling.

More data on the borrowing requirement and government debt:

https://www.riksgalden.se/en/For-investors/Borrowing-and-the-government-debt/

The monthly outcome of the central government net borrowing requirement is included in the official statistics of Sweden.

Attachment

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Heijmans and De Wever: 220 homes in Berkel-Enschot and Tilburg12.11.2019 17:30:00 CETPress release

Heijmans and geriatric care organization De Wever, which is an organisation that provides care to the elderly, have concluded a cooperation agreement for the phased development of approximately 220 owner-occupier and rental homes in Berkel-Enschot and Tilburg. Part of the homes (112 care apartments) is intended for senior citizens with divergent care needs. The project is valued at around € 65 million. Heijmans and De Wever respond to the increasing demand for suitable homes for senior citizens in Berkel-Enschot and Tilburg by means of this cooperation. Part of the apartments is intended for senior citizens who require nursing home care. With this project Heijmans contributes to creating a healthy living environment for these target groups. The project focuses among other things on laying out indoor and outdoor spaces intended for shared use, as a result of which residents can meet each other. A new apartment complex with 52 apartments for hospital (intramural) care is being realized i

Prosafe SE: Mandatory notification of trade12.11.2019 16:09:00 CETPress release

Ryan Stewart, Chief Commercial Officer, has on 12 November 2019 purchased 45,000 shares in Prosafe SE at an average price of NOK 4.2565 per share. Following the transaction, Ryan Stewart owns 45,260 shares in Prosafe SE. Prosafe is a leading owner and operator of semi-submersible accommodation vessels. The Company is listed on the Oslo Stock Exchange with ticker code PRS. For more information, please refer to www.prosafe.com Stavanger, 12 November 2019 Prosafe SE For further information, please contact: Jesper K. Andresen, CEO Phone: +47 51 65 24 30 / +47 907 65 155 Stig H. Christiansen, Deputy CEO and CFO Phone: +47 51 64 25 17 / +47 478 07 813 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

SDLP - Seadrill Partners LLC Third Quarter 2019 Cash Distribution12.11.2019 15:37:00 CETPress release

London, United Kingdom, November 12, 2019 - Seadrill Partners LLC (OTCQB:SDLPF) ("Seadrill Partners" or the "Company") announces today that a distribution of $0.01 per unit has been declared with respect to the third quarter ended September 30, 2019, in line with the second quarter distribution. The third quarter cash distribution will be paid on November 27, 2019 to all unitholders of record as of the close of business on November 22, 2019. FORWARD LOOKING STATEMENTS This news release includes forward looking statements. Such statements are generally not historical in nature, and specifically include statements about the Company's plans, strategies, business prospects, changes and trends in its business and the markets in which it operates. In particular, statements regarding offshore drilling markets, the Company's ability to make cash distributions, the expected performance of the drilling units in the Company's fleet, estimated duration of customer contracts, contract dayrate amoun

DNO ASA: FAPE01 bond buyback12.11.2019 15:25:00 CETPress release

Oslo, 12 November 2019 - DNO ASA, the Norwegian oil and gas operator, today purchased USD 2.6 million in nominal value of FAPE01 bonds (ISIN NO0010811268) originally issued by Faroe Petroleum plc, and renamed DNO North Sea plc. The bonds were purchased at a price of 107.25. Following the bond buyback, USD 23.6 million in nominal value of the FAPE01 bonds remain outstanding with DNO ASA holding the balance of USD 62.2 million. The FAPE01 bonds mature on 28 April 2023. -- For further information, please contact: Media: media@dno.no Investors: investor.relations@dno.no -- DNO ASA is a Norwegian oil and gas operator focused on the Middle East and the North Sea. Founded in 1971 and listed on the Oslo Stock Exchange, the Company holds stakes in onshore and offshore licenses at various stages of exploration, development and production in the Kurdistan region of Iraq, Norway, the United Kingdom, Netherlands, Ireland and Yemen. This information is subject to the disclosure requirements pursuant

PCI Biotech to present at BIO-Europe 201912.11.2019 15:11:00 CETPress release

Oslo, Norway, November 12, 2019 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present at BIO-Europe 2019 being held November 11-13, 2019 at Hamburg Messe, Germany. On Wednesday, November 13, 2019 at 09:15am (CET), Dr. Per Walday, CEO, will present an overview of PCI Biotech’s technology and the multiple business development and commercial opportunities available based on this proprietary platform. The presentation will be made available on PCI Biotech’s website (www.pcibiotech.com ) under “Other presentations”. About PCI Biotech PCI Biotech is a biopharmaceutical company focusing on development and commercialisation of novel therapies for the treatment of cancer through its innovative photochemical internalisation (PCI) technology platform. PCI is applied to three distinct anticancer paradigms: fimaChem (enhancement of chemotherapeutics for localised treatment of cancer), fi